The immunology of Parkinson’s disease

Kelly J, Moyeed R, Carroll C, Albani D, Li X (2019) Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease. Mol Brain 12(16):552

Google Scholar 

Yang W et al (2020) Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis 6:15

PubMed  PubMed Central  Article  Google Scholar 

G. B. D. P. s. D. (2018). Collaborators, Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17, 939-953

Moustafa AA et al (2016) Motor symptoms in Parkinson’s disease: a unified framework. Neurosci Biobehav Rev 68:727–740

PubMed  Article  Google Scholar 

Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:509

CAS  PubMed  Article  Google Scholar 

Mahlknecht P, Seppi K, Poewe W (2015) The concept of prodromal Parkinson’s disease. J Parkinsons Dis 5:681–697

PubMed  PubMed Central  Article  Google Scholar 

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397:2284–2303

CAS  PubMed  Article  Google Scholar 

Schilder BM, Navarro E, Raj T (2022) Multi-omic insights into Parkinson’s disease: from genetic associations to functional mechanisms. Neurobiol Dis 163:105580

CAS  PubMed  Article  Google Scholar 

Lesage S, Brice A (2009) Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48-59

CAS  PubMed  Article  Google Scholar 

Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S (2018) A review of genome-wide transcriptomics studies in Parkinson’s disease. Eur J Neurosci 47:1–16

PubMed  Article  Google Scholar 

Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548–560

PubMed  Article  Google Scholar 

Driver JA, Logroscino G, Gaziano JM, Kurth T (2009) Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 72:432–438

PubMed  PubMed Central  Article  Google Scholar 

Van Den Eeden SK et al (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022

Article  Google Scholar 

Poewe W et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013

PubMed  Article  Google Scholar 

Post B et al (2020) Young onset Parkinson’s disease: a modern and tailored approach. J Parkinsons Dis 10:S29–S36

PubMed  PubMed Central  Article  Google Scholar 

Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson’s disease. Front Neuroendocrinol 35:370–384

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cerri S, Mus L, Blandini F (2019) Parkinson’s disease in women and men: what’s the difference? J Parkinsons Dis 9:501–515

PubMed  PubMed Central  Article  Google Scholar 

Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry 75:637–639

CAS  PubMed  PubMed Central  Article  Google Scholar 

Braak H et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

PubMed  Article  Google Scholar 

Weinberger M, Hutchison WD, Dostrovsky JO (2009) Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia? Exp Neurol 219:59058–59061

Article  Google Scholar 

Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson’s disease. FEBS J 285:3657–3668

CAS  PubMed  PubMed Central  Article  Google Scholar 

Michely J et al (2015) Dopaminergic modulation of motor network dynamics in Parkinson’s disease. Brain 138:664–678

PubMed  PubMed Central  Article  Google Scholar 

Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Transl Neurodegener 4:19

PubMed  PubMed Central  Article  CAS  Google Scholar 

Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397

CAS  PubMed  Article  Google Scholar 

Lema Tome CM et al (2013) Inflammation and alpha-synuclein’s prion-like behavior in 600 Parkinson’s disease–is there a link? Mol Neurobiol 47:561–574

CAS  PubMed  Article  Google Scholar 

Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8(2804–2815):603

Google Scholar 

Robotta M et al (2014) Alpha-synuclein binds to the inner membrane of mitochondria in an 604 alpha-helical conformation. ChemBioChem 15:2499–2502

CAS  PubMed  Article  Google Scholar 

Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: 606 from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38–48

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schweighauser M et al (2020) Structures of alpha-synuclein filaments from multiple system 608 atrophy. Nature 585:464–469

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lucas HR, Fernandez RD (2020) Navigating the dynamic landscape of alpha-synuclein 610 morphology: a review of the physiologically relevant tetrameric conformation. Neural Regen Res 15:407–415

PubMed  Article  Google Scholar 

Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of alpha- 613 synuclein in Parkinson’s disease: insights from animal models. Nat Rev Neurosci 4:727–738

CAS  PubMed  Article  Google Scholar 

Quilty MC, Gai WP, Pountney DL, West AK, Vickers JC (2003) Localization of 616 alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma. Exp Neurol 182(195–207):618

Google Scholar 

Rekas A, Ahn KJ, Kim J, Carver JA (2012) The chaperone activity of alpha-synuclein: utilizing deletion mutants to map its interaction with target proteins. Proteins 80:1316–1325

CAS  PubMed  Article  Google Scholar 

Kamp F et al (2010) Inhibition of mitochondrial fusion by alpha-synuclein is rescued by 622 PINK1, Parkin and DJ-1. EMBO J 29:3571–3589

CAS  PubMed  PubMed Central  Article  Google Scholar 

L. Stefanis, (2012). alpha-Synuclein in Parkinson’s disease. Cold Spring Harb Perspect Med 2, 624a009399

Xu L, Pu J (2016) Alpha-synuclein in Parkinson’s disease: from pathogenetic dysfunction to 626 potential clinical application. Parkinsons Dis 2016:1720621

PubMed  PubMed Central  Google Scholar 

Angot E, Steiner JA, Hansen C, Li JY, Brundin P (2010) Are synucleinopathies prion-like 62 disorders? Lancet Neurol 9:1128–1138

PubMed  Article  Google Scholar 

Liao DH, Zhao JB, Gregersen H (2009) Gastrointestinal tract modelling in health and 630 disease. World J Gastroenterol 15:169–176

PubMed  PubMed Central  Article  Google Scholar 

Reed KK, Wickham R (2009) Review of the gastrointestinal tract: from macro to micro. Semin Oncol Nurs 25:3–14

PubMed  Article  Google Scholar 

Ohno H (2016) Intestinal M cells. J Biochem 159:151–160

CAS  PubMed  Article  Google Scholar 

Kitazawa T, Kaiya H (2019) Regulation of gastrointestinal motility by motilin and ghrelin in 635 vertebrates. Front Endocrinol (Lausanne) 10:278

Article  Google Scholar 

Duan H et al (2021) Regulation of the autonomic nervous system on intestine. Front Physiol 12:700129

PubMed  PubMed Central  Article  Google Scholar 

Swaminathan M, Fung C, Finkelstein DI, Bornstein JC, Foong JPP (2019) alpha- 639 Synuclein regulates development and function of cholinergic enteric neurons in the 640 mouse colon. Neuroscience 423:76–85

CAS  PubMed  Article  Google Scholar 

Bottner M et al (2015) Alpha-synuclein is associated with the synaptic vesicle apparatus in the 642 human and rat enteric nervous system. Brain Res 1614:51–59

PubMed  Article  CAS  Google Scholar 

Anis E, Xie A, Brundin L, Brundin P (2022) Digesting recent findings: gut alpha-synuclein, 644 microbiome changes in Parkinson’s disease. Trends Endocrinol Metab 33:147–157

CAS  PubMed 

留言 (0)

沒有登入
gif